AMLX Total Non-Current Liabilities
Amylyx Pharmaceuticals Inc · Total Non-Current Liabilities
AMLX Total Non-Current Liabilities
Latest reported$4.25Mperiod ending
AMLX Quarterly Total Non-Current Liabilities ($239.38M → $4.25M)
Quarterly total non-current liabilities
High-resolution chart · PNG
AMLX total non-current liabilities history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Liabilities (USD) |
|---|---|
| 4,247,000 | |
| 4,476,000 | |
| 4,698,000 | |
| 4,954,000 | |
| 5,297,000 | |
| 327,000 | |
| 463,000 | |
| 595,000 | |
| 772,000 | |
| 1,382,000 | |
| 1,980,000 | |
| 2,567,000 | |
| 3,141,000 | |
| 3,694,000 | |
| 4,237,000 | |
| 4,768,000 | |
| 5,287,000 | |
| 5,786,000 | |
| 239,386,000 | |
| 239,384,000 |